Abstract Categories

• Precision Oncology and Biomarker-Driven Therapeutics
• Translational Research and Drug Development
• Early-Phase Clinical Trials and Innovative Trial Design
• Clinical Trial Methodology and Novel Endpoints
• Emerging Immunotherapeutic Strategies
• Digital Pathology, AI, and Predictive Modeling in Oncology

Preclinical, translational, and clinical research will be considered.

Poster Types

Original Research Posters
Interim or final analyses of preclinical, translational, or clinical research studies.

Clinical Trials in Progress
Planned or ongoing clinical trials highlighting study design, treatment schema, eligibility
criteria, and scientific rationale.

Encore and/or Industry Posters

• Encore Posters are defined as posters previously presented at a national or international hematology/oncology conference within 16 months of the ACRS abstract submission deadline (February 2025).
• Encore posters may be submitted and presented, if accepted, by an author on the original abstract or an industry representative with permission.
• An Encore poster and/or poster presented by an industry representative will incur a fee
  of $2,500 per poster, if accepted.

Poster Specifications

Posters may not exceed 36” x 48”

A downloadable poster template is available HERE , or presenters may use their own design

Abstract Requirements

• Abstracts must be 250 words or fewer (titles, authors, and references not included in word count)
• Abstracts should include a clear statement of purpose and structured headings (e.g., Background, Methods, Results, Conclusions)
• All authors and institutional affiliations must be listed, with the presenting author in bold

Submission Deadline
Abstracts will be accepted from Monday, March 16, 2026 through 11:59 PM ET on Friday, June 12, 2026.

Submitting Online

All abstracts must be submitted through the online submission portal located HERE

Applicants must:

• Complete all sections of the application
• Submit a separate application for each abstract – if submitting more than 1
• Upload required documentation, including:
  • Abstract
  • CV or resume of presenting author or industry representative
  • COI disclosure forms for presenting author or industry representative
  • Supporting documentation of permission and COI disclosure form from the first author if:

• • • Presenting author is not the first author of the abstract
    • Industry representative is not an author on the abstract

Review and Notification

All submissions will undergo peer review for scientific quality and relevance.

Decision notifications will be emailed to the presenting author by Wednesday, July 8, 2026.

Presenter Responsibilities

Presenting a poster at the STOP Cancer Summit is voluntary. Horizon CME does not provide funding for travel or registration expenses. All presenting authors must register for the meeting
(at minimum for the day of their presentation).

All questions should be directed to Caitlin Sutton, PharmD, at
caitlin.sutton@horizoncme.com